Science

AddToAny

Google+ Facebook Twitter Twitter

British Journal of Biomedical Science: second quarter 2022

Deputy Editor Dr Mark Hajjawi gives a round-up of the papers published over recent months.

With the showers of spring behind us, roses now in bloom, and the summer sun shining across the UK, now is a good opportunity to look back over the second quarter of 2022. With Professor Anthony Rhodes as Editor, the journal has settled into its new home with the publisher, Frontiers, and it continues to publish world-leading research from international authors. Two new Deputy Editors have been appointed, Dr Mark Hajjawi from Scarborough, Hull and York Pathology Service and Dr Yuh-Fen Pung from the University of Nottingham Malaysia, to join Dr Guy Orchard and Dr Andrew Blann.

COVID-19

We will continue 2022 as we began it, focusing on COVID-19. Almost all biomedical scientists practising in healthcare will have been affected by COVID-19 professionally, and this condition continues to devastate society. The journal has previously published articles which identified mortality risk factors associated with COVID-19. Adding to this body of work, El-Lateef et al. investigated haemostatic changes in 284 patients with COVID-19 who presented at the Security Forces Hospital in Makkah, Saudi Arabia. 

Please click here to read the full article.

Image credit | Shutterstock

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top